| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |